AstraZeneca PLC(AZN)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
AZN | 261.94 B | 25.44x | 12.50% | 17.19% | $6.64 | 23.48% | 0.72 | 1.67% | $210.52 | $134.87 |
AZN.L | 19.46 T | 2494.23x | 12.50% | 17.19% | $5.03 | 23.48% | 0.72 | 1.68% | $15730.38 | $10101.26 |
GSK.L | 7.65 T | 1344.72x | 1.50% | 17.78% | $1.42 | 40.91% | 1.10 | 3.43% | $2281.61 | $1288.27 |
HLN.L | 3.27 T | 2060.56x | 0.60% | 15.11% | $0.18 | 10.27% | 0.52 | 2.04% | $416.04 | $274.36 |
HIK.L | 326.81 B | 1133.58x | 8.50% | 12.00% | $1.37 | 16.52% | 0.62 | 4.06% | $2051.03 | $1186.67 |
Peer Valuation & Performance Analysis
Peer group analysis for AstraZeneca PLC (AZN) compared to its primary competitors (including AZN.L, GSK.L, HLN.L) reveals distinct metrics. AZN trades at a valuation discount relative to its competitors, with a P/E ratio of 25.4x versus the peer average of 1758.3x (representing a 99% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, AZN's revenue growth of 12.5% exceeds the peer average of 5.8%, highlighting its competitive strength and market share gains. Additionally, its net margin of 17.2% is comparable to the peer average of 15.5%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• AZN ranks #1 in P/E ratio, #1 in revenue growth, and #2 in profit margins
• Average ranking: #1 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-07-17 | $168.15 | $170.31 | $167.15 | $168.90 | 1,980,800 | +0.45% |
| 2026-07-16 | $167.97 | $170.37 | $167.25 | $169.29 | 3,018,300 | +0.79% |
| 2026-07-15 | $166.22 | $169.58 | $166.21 | $168.37 | 2,938,200 | +1.29% |
| 2026-07-14 | $167.36 | $168.10 | $164.45 | $164.50 | 3,605,500 | -1.71% |
| 2026-07-13 | $168.75 | $170.47 | $168.11 | $169.47 | 4,666,100 | +0.43% |
| 2026-07-10 | $175.49 | $175.88 | $171.42 | $171.61 | 3,594,800 | -2.21% |
| 2026-07-09 | $173.45 | $180.21 | $172.76 | $178.49 | 6,648,400 | +2.91% |
| 2026-07-08 | $189.95 | $191.48 | $188.67 | $189.28 | 1,967,800 | -0.35% |
| 2026-07-07 | $192.98 | $193.79 | $191.60 | $193.12 | 2,129,500 | +0.07% |
| 2026-07-06 | $190.20 | $190.24 | $186.24 | $190.16 | 1,872,000 | -0.02% |
| 2026-07-02 | $189.52 | $196.41 | $189.17 | $195.15 | 2,379,500 | +2.97% |
| 2026-07-01 | $187.07 | $187.65 | $183.49 | $183.86 | 2,115,500 | -1.72% |
| 2026-06-30 | $190.31 | $190.46 | $186.16 | $189.62 | 2,598,700 | -0.36% |
| 2026-06-29 | $189.25 | $191.13 | $188.45 | $190.95 | 1,644,300 | +0.90% |
| 2026-06-26 | $184.28 | $189.57 | $184.28 | $188.41 | 3,235,300 | +2.24% |